Electra Therapeutics, Inc. (ETRA)

Electra Therapeutics will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Electra Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Net Income	-85.53	-61.98	-24.79
Depreciation & Amortization	-0.61	-0.19	-0.72
Share-Based Compensation	-	1.77	2.31
Other Operating Activities	11.46	-0.1	-2.8
Operating Cash Flow	-74.68	-60.48	-26
Operating Cash Flow Growth	-	-	-

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Capital Expenditures	-0.64	-0.73	-
Change in Investments	-	-52.25	29.7
Investing Cash Flow	-31.09	-52.98	29.7

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Share Issuance / Repurchase	-	91.68	-
Debt Issued / Paid	-	40	-
Financing Cash Flow	141.29	131.68	-

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Net Cash Flow	35.53	18.22	3.7

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Free Cash Flow	-75.32	-61.22	-26
Free Cash Flow Growth	-	-	-